The Vape Club Show Moscow, an e-cigarette exhibition, was held on June 17th and 18th at the Crocus Expo exhibition center in Moscow. As the official media partner, 2FIRSTS provided comprehensive live coverage of the event.
At the exhibition, 2FIRSTS interviewed the WIPO Russian market manager for e-cigarette brand, Daria. She stated that the offline ban on displaying e-cigarettes in Russia, which came into effect on June 1st, has little impact on them, but the online ban on sales and marketing has a greater impact.
Daria stated that although the display of e-cigarettes is banned offline, it does not affect orders from major clients. However, the online prohibition of sales and marketing has made it difficult for them to expand their customer base, as they can only promote their products through phone calls to customers.
Dalia holds a positive outlook on Russia's proposed e-cigarette regulation measures, which are currently a topic of discussion. Though the effects remain uncertain, she believes that the changes will likely be minimal.
Dalia explained that the majority of products produced by WIPO are disposable, as consumers find refillable products to be inconvenient and prefer using disposable ones. Therefore, the market for disposable products is larger compared to refillable ones.
When discussing the issue of illegal products in the Russian market, Daria stated that it is difficult for brand owners to avoid the problem of counterfeit goods. Head brands such as HQD and ELFBAR have also been deeply affected by fake and inferior products.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
